All News

    Datroway May Be Effective in Non-Small Cell Lung Cancer Subtypes

    February 27th 2025, 4:00pm

    Article

    Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic alterations, including EGFR and ALK subgroups.

    Metronomic Capecitabine and an AI Improve Survival in HR+/HER2– Metastatic Breast Cancer

    February 27th 2025, 2:00pm

    Article

    Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative metastatic breast cancer.

    Off-The-Shelf CAR T Therapy Elicits Responses in Large B-Cell Lymphoma

    February 26th 2025, 10:00pm

    Video

    Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.

    A Study Investigates If CAR T Therapy Directly Causes Secondary Malignancies

    February 26th 2025, 8:00pm

    Video

    There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.

    The Bittersweet Blessings of Being a Young Adult Cancer Survivor

    February 26th 2025, 6:00pm

    Article

    Being a young adult cancer survivor is bittersweet, bringing both unique struggles and unexpected blessings that shape my life, career and perspective.

    Minimal Residual Disease Testing’s Variability Across Cancer Types

    February 26th 2025, 5:00pm

    Video

    Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and monitoring based on disease characteristics.

    What Patients With Breast Cancer Need to Know About Itovebi and Blood Sugar

    February 26th 2025, 4:24pm

    Video

    An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.

    Delving Into Clinical Research For Patients With Breast Cancer

    February 26th 2025, 4:12pm

    Video

    Dr. Yuan Yuan breaks down studies for patients with breast cancer, such as the phase 3 CompassHER2 RD Trial.

    Clinical Trials to Watch in Triple-Negative Breast Cancer

    February 26th 2025, 4:03pm

    Video

    An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

    FDA Accepts sBLA For Opdivo Plus Yervoy For Some Patients with mCRC

    February 26th 2025, 2:00pm

    Article

    The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult and pediatric patients with colorectal cancer.